Charlie Hospital Semarang Tbk PT

The company's capital structure is characterized by a debt-to-equity ratio of 0.32, indicating a relatively conservative leverage position. However, the liquidity risk is rated as medium, with a current ratio of 0.52, suggesting that the company may struggle to meet its short-term obligations. The negative operating cash flow of -6,193,955,460 IDR and free cash flow of -40,127,124,830 IDR further highlight the company's liquidity challenges. Profitability metrics are concerning, with a return on equity of -12.58% and a return on assets of -8.11%, both significantly below the industry median for healthcare facilities and services. The company reported a net loss of 16,420,240,770 IDR, and an operating loss of 11,249,588,050 IDR, indicating a need for operational improvements to align with industry standards. The company's revenue is concentrated in a single geographic region, as disclosed segments do not provide a breakdown of geographic exposure. This lack of diversification increases the company's vulnerability to regional economic or regulatory changes. The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. The negative operating and free cash flows suggest a lack of momentum in revenue generation and operational efficiency. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to fund operations without external financing. The dilution potential is low, with no significant adjustments applied to the valuation metrics. Recent events, as disclosed in the company's financial filings, include a significant capital expenditure of -43,573,533,770 IDR, which may indicate investments in infrastructure or expansion. However, the negative cash flows suggest that these investments have not yet translated into positive returns.